These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1056 related articles for article (PubMed ID: 28040437)
41. SKLB1002, a novel potent inhibitor of VEGF receptor 2 signaling, inhibits angiogenesis and tumor growth in vivo. Zhang S; Cao Z; Tian H; Shen G; Ma Y; Xie H; Liu Y; Zhao C; Deng S; Yang Y; Zheng R; Li W; Zhang N; Liu S; Wang W; Dai L; Shi S; Cheng L; Pan Y; Feng S; Zhao X; Deng H; Yang S; Wei Y Clin Cancer Res; 2011 Jul; 17(13):4439-50. PubMed ID: 21622720 [TBL] [Abstract][Full Text] [Related]
42. Capilliposide B blocks VEGF-induced angiogenesis in vitro in primary human retinal microvascular endothelial cells. Han H; Yang Y; Wu Z; Liu B; Dong L; Deng H; Tian J; Lei H Biomed Pharmacother; 2021 Jan; 133():110999. PubMed ID: 33227710 [TBL] [Abstract][Full Text] [Related]
43. Pro-angiogenic activity of astragaloside IV in HUVECs in vitro and zebrafish in vivo. Zhang Y; Hu G; Li S; Li ZH; Lam CO; Hong SJ; Kwan YW; Chan SW; Leung GP; Lee SM Mol Med Rep; 2012 Mar; 5(3):805-11. PubMed ID: 22179585 [TBL] [Abstract][Full Text] [Related]
44. Anti-angiogenic effect of adiponectin in human primary microvascular and macrovascular endothelial cells. Palanisamy K; Nareshkumar RN; Sivagurunathan S; Raman R; Sulochana KN; Chidambaram S Microvasc Res; 2019 Mar; 122():136-145. PubMed ID: 30144414 [TBL] [Abstract][Full Text] [Related]
45. BET Bromodomain Suppression Inhibits VEGF-induced Angiogenesis and Vascular Permeability by Blocking VEGFR2-mediated Activation of PAK1 and eNOS. Huang M; Qiu Q; Xiao Y; Zeng S; Zhan M; Shi M; Zou Y; Ye Y; Liang L; Yang X; Xu H Sci Rep; 2016 Apr; 6():23770. PubMed ID: 27044328 [TBL] [Abstract][Full Text] [Related]
46. Gamabufotalin, a major derivative of bufadienolide, inhibits VEGF-induced angiogenesis by suppressing VEGFR-2 signaling pathway. Tang N; Shi L; Yu Z; Dong P; Wang C; Huo X; Zhang B; Huang S; Deng S; Liu K; Ma T; Wang X; Wu L; Ma XC Oncotarget; 2016 Jan; 7(3):3533-47. PubMed ID: 26657289 [TBL] [Abstract][Full Text] [Related]
47. Curcumin inhibits angiogenesis and improves defective hematopoiesis induced by tumor-derived VEGF in tumor model through modulating VEGF-VEGFR2 signaling pathway. Fu Z; Chen X; Guan S; Yan Y; Lin H; Hua ZC Oncotarget; 2015 Aug; 6(23):19469-82. PubMed ID: 26254223 [TBL] [Abstract][Full Text] [Related]
48. The impact of the receptor binding profiles of the vascular endothelial growth factors on their angiogenic features. Nieminen T; Toivanen PI; Rintanen N; Heikura T; Jauhiainen S; Airenne KJ; Alitalo K; Marjomäki V; Ylä-Herttuala S Biochim Biophys Acta; 2014 Jan; 1840(1):454-63. PubMed ID: 24112971 [TBL] [Abstract][Full Text] [Related]
49. Molecular mechanism of inhibition of the abnormal proliferation of human umbilical vein endothelial cells by hydroxysafflor-yellow A. Wang J; Wang J; Wang X; Liu L; Hu J; Yu X; Xu Y; Niu X; Lin Z; Zhang Y; Zhang X; Zhang Q Pharm Biol; 2016 Sep; 54(9):1800-7. PubMed ID: 26730646 [TBL] [Abstract][Full Text] [Related]
50. Suppression of alpha-tocopherol ether-linked acetic acid in VEGF-induced angiogenesis and the possible mechanisms in human umbilical vein endothelial cells. Chuang CH; Liu CH; Lu TJ; Hu ML Toxicol Appl Pharmacol; 2014 Dec; 281(3):310-6. PubMed ID: 25447407 [TBL] [Abstract][Full Text] [Related]
51. Anti-angiogenic activity and mechanism of kaurane diterpenoids from Wedelia chinensis. Huang W; Liang Y; Wang J; Li G; Wang G; Li Y; Chung HY Phytomedicine; 2016 Mar; 23(3):283-92. PubMed ID: 26969382 [TBL] [Abstract][Full Text] [Related]
52. Oridonin exhibits anti-angiogenic activity in human umbilical vein endothelial cells by inhibiting VEGF-induced VEGFR-2 signaling pathway. Jiang JH; Pi J; Cai JY Pathol Res Pract; 2020 Aug; 216(8):153031. PubMed ID: 32703495 [TBL] [Abstract][Full Text] [Related]
53. Domain I-IV of β2-glycoprotein I inhibits advanced glycation end product-induced angiogenesis by down-regulating vascular endothelial growth factor 2 signaling. Wang QQ; Zhou SJ; Meng ZX; Wang J; Chen R; Lv L; Li CJ; Yu DM; Yu P Mol Med Rep; 2015 Mar; 11(3):2167-72. PubMed ID: 25405610 [TBL] [Abstract][Full Text] [Related]
54. Kaempferol inhibits angiogenic ability by targeting VEGF receptor-2 and downregulating the PI3K/AKT, MEK and ERK pathways in VEGF-stimulated human umbilical vein endothelial cells. Chin HK; Horng CT; Liu YS; Lu CC; Su CY; Chen PS; Chiu HY; Tsai FJ; Shieh PC; Yang JS Oncol Rep; 2018 May; 39(5):2351-2357. PubMed ID: 29565448 [TBL] [Abstract][Full Text] [Related]
55. Quercetin-4'-O-β-D-glucopyranoside (QODG) inhibits angiogenesis by suppressing VEGFR2-mediated signaling in zebrafish and endothelial cells. Lin C; Wu M; Dong J PLoS One; 2012; 7(2):e31708. PubMed ID: 22348123 [TBL] [Abstract][Full Text] [Related]
56. Penduliflaworosin, a Diterpenoid from Croton crassifolius, Exerts Anti-Angiogenic Effect via VEGF Receptor-2 Signaling Pathway. Liang Y; Zhang Y; Wang G; Li Y; Huang W Molecules; 2017 Jan; 22(1):. PubMed ID: 28098802 [TBL] [Abstract][Full Text] [Related]
57. Selenadiazole Derivatives Inhibit Angiogenesis-Mediated Human Breast Tumor Growth by Suppressing the VEGFR2-Mediated ERK and AKT Signaling Pathways. Lai H; Fu X; Sang C; Hou L; Feng P; Li X; Chen T Chem Asian J; 2018 Jun; 13(11):1447-1457. PubMed ID: 29575811 [TBL] [Abstract][Full Text] [Related]
58. Pristimerin, a triterpenoid, inhibits tumor angiogenesis by targeting VEGFR2 activation. Mu X; Shi W; Sun L; Li H; Jiang Z; Zhang L Molecules; 2012 Jun; 17(6):6854-68. PubMed ID: 22669041 [TBL] [Abstract][Full Text] [Related]